XC
TMO icon

XY Capital’s Thermo Fisher Scientific TMO Stock Holding History

XY Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,300
Closed -$753K – 280
2025
Q4 		$753K Buy
+1,300
New +$735K 0.47% 44
2025
Q2 		– Sell
-1,200
Closed -$597K – 198
2025
Q1 		$597K Buy
+1,200
New +$650K 0.17% 105

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

XY Capital's TMO Position: Q1 2026 in Review

XY Capital sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 92 shares — an estimated $53.3K sold.

XY Capital first reported a position in TMO in Q1 2025 and held it in 2 quarters. The position peaked at $350K in Q1 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • XY Capital reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • XY Capital sold 92 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.3K.
  • XY Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 2 quarters.
  • XY Capital's Thermo Fisher Scientific position peaked at $350K in Q1 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on XY Capital's 13F filing for Q1 2026, filed 12 May 2026.